Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI and BioSpherix sign co-marketing agreement
Phase Holographic Imaging (PHI) and BioSpherix recently signed a collaboration agreement aiming to co-market the companies’ complementary product lines. BioSpherix, NY USA, manufactures and markets advanced cell incubators.
Learn more …
PostNews
Biostock interview with CEO Peter Egelberg
Learn more …
PostNews
![QUT_scientists_HoloMonitor_Twitter](https://phiab.com/wp-content/uploads/2018/05/QUT_scientists_HoloMonitor_Twitter.jpg)
New CEO commentary — “Redefining aging with HoloMonitor”
In the CEO commentary “Redefining aging with HoloMonitor” Peter Egelberg comments on the promising research results that were recently reported by Australian television.
Learn more …
PostNews
![](https://phiab.com/wp-content/uploads/2018/05/PHI_Nordic_Microscopy_Society_Meeting.jpg)
PHI at the Nordic Microscopy Society meeting, June 25-28
The Nordic Microscopy Society meeting in Lyngby Denmark offers several opportunities to meet with us and to hear about the latest HoloMonitor news.
Learn more …
PostPress Release
Notice of Extraordinary General Meeting in Phase Holographic Imaging PHI AB (publ)
Notice to the shareholders in Phase Holographic Imaging AB (publ), 556542-7811, to attend an Extraordinary General Meeting on Monday June 18 at 06.00 PM (18.00) at PHI’s office, Scheelevägen 22, Lund.
Learn more …
PostNews: Press Release
Decision on rights issue for continued growth, establishment of sales organization and commercial break-through
The Board of directors of Phase Holographic Imaging PHI AB (publ) (”PHI”) has decided to conduct a rights issue of units, which is subject to approval on Extraordinary General Meeting, that can provide the company a total of SEK 64.6 million at the most prior to issuing costs.
Learn more …